A股異動 | 雲中馬跌超8%,擬定增募資不超過6.4億
雲中馬(603130.SH)跌超8%,報26.09元,總市值35.88億元。雲中馬23日晚間披露定增預案,擬募資不超過6.4億元,用於年產13.5萬噸DTY絲及12萬噸高性能革基布坯布項目。本次發行對象爲不超過35名特定投資者,包括符合證監會規定條件的證券投資基金管理公司、證券公司、信託投資公司、財務公司、保險機構投資者、合格境外機構投資者以及其他符合法律法規規定的法人、自然人或其他機構投資者。發行價不低於定價基準日前20個交易日股票交易均價的80%,發行股數不超過4125.43萬股,不超過本次發行前公司總股本的30%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.